Hester Biosciences Ltd — Board/Management Information 2019

Dec 18, 2019

==> picture [521 x 95] intentionally omitted <==

18 December 2019

To, To, BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers, Exchange Plaza, Dalal Street, Bandra - Kurla Complex, Mumbai - 400 001 Bandra (E), Mumbai - 400 051 Scrip Code: 524669 Symbol: HESTERBIO

Respected Sir / Madam,

Subject: Outcome of Board Meeting held today

Start Time: 10.30 am Conclusion Time: 10.55 am

This is in reference to our letter dated 13 December 2019 intimating the date of the Board Meeting for consideration of the proposal of raising of funds by way of issue of equity shares, and/or equity linked securities and/or securities convertible into equity shares through Qualified Institutional Placement (QIP) or preferential allotment:

Pursuant to the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that Board of Directors, in their Meeting held today, have approved the followings:

1. Issuance of equity shares, and/or equity linked securities and/or securities convertible into equity shares through Qualified Institutional Placement (QIP) or preferential allotment for an amount not exceeding INR 150 crores, subject to approval of members through Postal Ballot process.

2. Re-appointment of Mr. Rajiv Gandhi, CEO & Managing Director of the Company for the period of 3 years from 1 April 2020 to 31 March 2023, subject to approval of Members through Postal Ballot process.

You are requested to take the above information on your record.

Sincerely, For Hester Biosciences Limited

==> picture [53 x 55] intentionally omitted <==

Rajiv Gandhi CEO & Managing Director DIN: 00438037